Ignite Creation Date:
2024-05-05 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00147901
Status:
COMPLETED
Last Update Posted:
2016-10-03
First Post:
2005-09-02
Brief Title:
Fludarabine Cyclophosphamide and Alemtuzumab in Patients With B-cell Chronic Lymphatic Leukemia B-CLL
Sponsor:
German CLL Study Group
Organization:
German CLL Study Group